Florida-based Ocenture LLC and Carelumina LLC, its subsidiary, have agreed to pay $3 million to resolve allegations that they caused false Medicare claims through kickbacks involving genetic testing samples, the Department of Justice said Thursday.
Ocenture allegedly paid physicians to falsely claims that genetic testing samples from Medicare beneficiaries were medically necessary so that a portion of the reimbursement could be paid to Ocenture, according to the DOJ.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.